SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant [_]
Filed by a Party other than the Registrant [X]
Check the appropriate box:
[_] Preliminary Proxy Statement [_] Confidential, For Use of the
[_] Definitive Proxy Statement Commission Only (as permitted
[_] Definitive Additional Materials by Rule 14a-6(e)(2))
[X] Soliciting Material Pursuant to
Rule 14a-11(c) or Rule 14a-12
ICN PHARMACEUTICALS, INC.
--------------------------------------------------------------------------------
(Name of Registrant as Specified In Its Charter)
SSP - Special Situations Partners, Inc.
--------------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
[X] No fee required.
[_] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
--------------------------------------------------------------------------------
1) Title of each class of securities to which transaction applies:
--------------------------------------------------------------------------------
2) Aggregate number of securities to which transaction applies:
--------------------------------------------------------------------------------
3) Per unit price or other underlying value of transaction computed pursuant
to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is
calculated and state how it was determined):
--------------------------------------------------------------------------------
4) Proposed maximum aggregate value of transaction:
--------------------------------------------------------------------------------
5) Total fee paid:
--------------------------------------------------------------------------------
[_] Fee paid previously with preliminary materials:
--------------------------------------------------------------------------------
[_] Check box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee
was paid previously. Identify the previous filing by registration
statement number, or the form or schedule and the date of its filing.
1) Amount previously paid:
--------------------------------------------------------------------------------
2) Form, Schedule or Registration Statement No.:
--------------------------------------------------------------------------------
3) Filing Party:
--------------------------------------------------------------------------------
4) Date Filed:
--------------------------------------------------------------------------------
<PAGE>
SSP Special Situations Partners, Inc. ("SSP") has established a website in order
to permit stockholders of ICN Pharmaceuticals, Inc. ("ICN") and other interested
parties to obtain access to materials filed by SSP with the United States
Securities and Exchange Commission (the "SEC") and other relevant material, and
to facilitate stockholder communication with SSP.
The SSP website address is: www.SSP-specialsituationspartners.com
The contents of the SSP website have previously been filed with the SEC,
including pursuant to a separate Schedule 14A filed on September 18, 2000.
----------------------------
Prior to soliciting proxies with respect to ICN, SSP will file with the SEC, and
will furnish to security holders of ICN a proxy statement, which security
holders are advised to read as it will contain important information. Security
holders may obtain a free copy of such proxy statement (when available) and
other related documents filed by SSP and ICN on the SSP website, as well as from
the SEC website at www.sec.gov. When available, the proxy statement may also be
obtained from SSP, at c/o Fidinam (Monte Carlo) SAM - Monte Carlo Palace, 7
boulevard des Moulins, MC 98000 Monaco.
Information concerning the identity of SSP and of each of the executive officers
and directors of SSP who may be deemed to be participants in any solicitation by
SSP of proxies with respect to ICN, including a description of their direct and
indirect interests in ICN, may be obtained from the Schedule 13D, dated November
15, 1999, as amended with respect to ICN filed by SSP with the SEC, and
available on the SSP website.
